ENDRA Life Sciences (NDRA) Gains from Investment Securities (2019 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Gains from Investment Securities of $8857.0 for Q1 2026, up 3120.73% YoY from $275.0 in Q1 2025, and up 107.63% sequentially from -$116137.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Gains from Investment Securities (2019 - 2026) Analysis & Trends
ENDRA Life Sciences has disclosed Gains from Investment Securities across 8 years of filings, most recently posting $8857.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 3120.73% year-over-year to $8857.0; the TTM figure through Mar 2026 stood at $4.1 million (up 1485806.18% YoY), while the FY2025 annual figure was $236.0, changed 0.0% from the prior year.
- Gains from Investment Securities improved to $8857.0 in Q1 2026, from -$116137.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for NDRA reached as high as $8.0 million in Q3 2022 and fell as low as -$116137.0 in Q4 2025.
- The 5-year median for Gains from Investment Securities is $505816.0 (2022), against an average of $1.6 million.
- The widest YoY moves for Gains from Investment Securities: up 989803.7% in 2025, down 102.96% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $505816.0 in 2022, then tumbled by 45.8% to $274128.0 in 2023, then surged by 1332.27% to $3.9 million in 2024, then tumbled by 102.96% to -$116137.0 in 2025, then soared by 107.63% to $8857.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $8857.0, -$116137.0, and $267274.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,857.00 |
| Mar 31, 2026 | 8,857.00 |
| Dec 31, 2025 | -116,137.00 |
| Dec 31, 2025 | -116,137.00 |
| Sep 30, 2025 | 267,274.00 |
| Sep 30, 2025 | 267,274.00 |
| Jun 30, 2025 | 266.00 |
| Jun 30, 2025 | 266.00 |
| Mar 31, 2025 | -408,562.00 |
| Mar 31, 2025 | -408,562.00 |
| Dec 31, 2024 | 3.93 Mn |
| Dec 31, 2024 | 3.93 Mn |
| Sep 30, 2024 | -3.34 Mn |
| Sep 30, 2024 | -3.34 Mn |
| Jun 30, 2024 | 679,187.00 |
| Jun 30, 2024 | 679,187.00 |
| Sep 30, 2023 | 274,128.00 |
| Sep 30, 2023 | 274,128.00 |
| Jun 30, 2023 | 646,449.00 |
| Jun 30, 2023 | 646,449.00 |